Ipatasertib Recruiting Phase 1 / 2 Trials for Triple Negative Breast Cancer (TNBC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs